Table 1.
Cancer groups, number of cases included and data quality indicators, 2002–2013.
| Cancer Groups | ICD-10 Codes | Number of Eligible Cases | Excluded, % | Number of Cases Included (%) | Data Quality Indicators, % | |||
|---|---|---|---|---|---|---|---|---|
| DCO | Diagnosed at Autopsy | Microscopically Verified | Non-Specific Morphology a | Lost to Follow-Up b | ||||
| Oral cavity and pharynx | C01–C06, C09–14 | 14,939 | 0.64 | 0.11 | 14,828 (99.26) | 98.73 | 1.50 | 0.26 |
| Esophagus | C15 | 6442 | 1.60 | 0.20 | 6326 (98.20) | 95.78 | 4.47 | 0.40 |
| Stomach | C16 | 21,748 | 2.21 | 0.43 | 21,175 (97.37) | 94.63 | 5.77 | 0.25 |
| Colon | C18 | 58,307 | 1.75 | 0.32 | 57,097 (97.92) | 94.93 | 5.38 | 0.14 |
| Rectum | C19–C20 | 28,990 | 0.63 | 0.20 | 28,750 (99.17) | 97.26 | 3.01 | 0.15 |
| Liver | C22 | 14,863 | 4.44 | 0.69 | 14,101 (94.87) | 43.93 | 37.08 | 0.35 |
| Gallbladder and bile ducts c | C23–C24 | 6865 | 2.08 | 0.52 | 6686 (97.39) | 65.99 | 34.89 | 0.27 |
| Pancreas | C25 | 15,685 | 4.07 | 0.54 | 14,962 (95.39) | 61.72 | 40.22 | 0.30 |
| Larynx | C32 | 10,636 | 0.80 | 0.03 | 10,548 (99.17) | 98.52 | 1.80 | 0.20 |
| Lung, bronchus and trachea c | C33–34 | 66,692 | 2.21 | 0.42 | 64,938 (97.37) | 87.20 | 13.62 | 0.32 |
| Skin melanoma | C43 | 12,857 | 0.32 | 0.05 | 12,809 (99.63) | 99.63 | 0.00 | 0.30 |
| Breast (women only) | C50 | 67,186 | 0.75 | 0.01 | 66,670 (99.23) | 98.55 | 1.69 | 0.25 |
| Cervix uteri | C53 | 5674 | 0.55 | 0.00 | 5643 (99.45) | 98.90 | 1.45 | 0.87 |
| Corpus uteri | C54 | 14,912 | 0.50 | 0.07 | 14,827 (99.43) | 98.14 | 1.98 | 0.20 |
| Ovary and annexes | C56, C570–C574, C577 | 8635 | 1.97 | 0.24 | 8444 (97.79) | 91.38 | 9.53 | 0.28 |
| Prostate | C61 | 77,920 | 1.40 | 0.19 | 76,682 (98.41) | 91.38 | 8.62 | 0.16 |
| Testicle | C62 | 3102 | 0.16 | 0.10 | 3094 (99.74) | 99.22 | 0.94 | 0.52 |
| Kidney | C64 | 13,912 | 1.32 | 0.71 | 13,630 (97.97) | 83.09 | 17.23 | 0.21 |
| Urinary bladder | C67, D090, D414 | 47,058 | 0.76 | 0.09 | 46,659 (99.15) | 95.75 | 4.94 | 0.12 |
| Brain | C71 | 9404 | 2.46 | 0.38 | 9137 (97.16) | 69.94 | 18.44 | 0.42 |
| Thyroid | C73 | 9176 | 0.20 | 0.73 | 9091 (99.07) | 99.33 | 0.79 | 0.34 |
| Hodgkin lymphoma | C81 | 3531 | 0.03 | 0.57 | 3510 (99.41) | 99.97 | 0.00 | 0.34 |
| Non-Hodgkin lymphoma | C82–C86, C96 | 18,691 | 0.81 | 0.56 | 18,435 (98.63) | 98.06 | 9.74 | 0.23 |
| Myeloma | C90 | 7421 | 1.68 | 0.19 | 7282 (98.13) | 93.79 | 0.00 | 0.15 |
| Acute lymphoid leukemia | C910 | 760 | 0.53 | 0.26 | 754 (99.21) | 99.73 | 0.00 | 0.13 |
| Chronic lymphoid leukemia | C911 | 5293 | 0.36 | 0.06 | 5271 (99.58) | 99.37 | 0.00 | 0.23 |
| Acute myeloid leukemia | C920, C923–C928, C930, C940–C946 | 4246 | 0.00 | 0.00 | 4246 (100.00) | 99.48 | 0.00 | 0.33 |
| Chronic myeloid leukemia | C921 | 1302 | 0.69 | 0.00 | 1293 (99.31) | 99.85 | 0.00 | 0.23 |
| Leukemia NOS and others | C913; C914; C915; C916; C917; C918; C919; C929; C931; C947; C950; C959 | 2321 | 11.72 | 0.26 | 2043 (88.02) | 90.16 | 39.94 | 0.34 |
| Other cancers d | 54,405 | 3.46 | 0.37 | 52,319 (96.17) | 85.91 | 14.68 | 0.23 | |
| All cancers d | C00–C96 (except C44), D090, D414, D45–D47 | 612,973 | 1.64 | 0.27 | 601,250 (98.09) | 91.03 | 8.97 | 0.23 |
Abbreviations: ICD-10, International Classification of Diseases—10th revision; DCO, Cases known by death certificate only; NOS, not otherwise specified. a Non-specific morphology: International Classification of Diseases for Oncology codes, 3rd edition, 8000–8005 (solid tumors) and 9590, 9591, 9800, 9801, 9805, 9820, 9832 or 9860 (hematological neoplasms). b Cases censored alive before five years from diagnosis unless they were censored due to the end of follow-up (31 December 2015). c Note that the group referred in the text to as “gallbladder” includes gallbladder and bile ducts; and the group referred to as “lung” includes lung, bronchus and trachea. d Excluding non-melanoma skin cancer.